Skip to main content
Bilal Siddiqui, MD, Internal Medicine, Boston, MA

BilalAhmedSiddiquiMD

Internal Medicine Boston, MA

Physician

Dr. Siddiqui is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Siddiqui's full profile

Already have an account?

  • Office

    330 Brookline Ave
    Boston, MA 02215
    Phone+1 617-667-7000

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2015 - 2018
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2015 - 2016
  • Yale School of Medicine
    Yale School of MedicineClass of 2015

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2019 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Clinical and immunological analyses of immune checkpoint inhibitor-associated neuromuscular (NM) toxicities. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Cytokine Release Syndrome and Neurotoxicity After CAR T-cell Therapy
    Cytokine Release Syndrome and Neurotoxicity After CAR T-cell TherapySeptember 20th, 2024